Triple Intralesional Immunotherapy Combination in Multiple Recalcitrant Warts

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Triple Intralesional Immunotherapy Combination in Multiple Recalcitrant Warts trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

CompletedPhase 2/3

NCT05254561

Triple Antigen vs Monoantigen Immunotherapy for Warts

Warts can be resistant to treatment or return despite the use of many therapeutic modalities. Combining immunotherapy might contribute to better response rates,…

Egypt160 participantsStarted 2020-11-20

Treatment: Intralesional antigen immunotherapy